INVESTIGACIÓN EN ONCOLOGÍA DE CABEZA Y CUELLO
IOCC
Harvard Medical School
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Harvard Medical School (13)
2024
2023
-
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer
Cancer research, Vol. 83, Núm. 19, pp. 3284-3304
-
Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review †
Cancers, Vol. 15, Núm. 3
-
The Role of Vitamin D in Autoimmune Thyroid Diseases: A Narrative Review †
Journal of Clinical Medicine, Vol. 12, Núm. 4
2022
-
A Distinct Chromatin State Drives Therapeutic Resistance in Invasive Lobular Breast Cancer
Cancer research, Vol. 82, Núm. 20, pp. 3673-3686
-
Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk (Nature Communications, (2022), 13, 1, (151), 10.1038/s41467-021-27666-x)
Nature Communications
-
Current therapeutic options for low-risk papillary thyroid carcinoma: Scoping evidence review
Head and Neck, Vol. 44, Núm. 1, pp. 226-237
-
Functional dissection of inherited non-coding variation influencing multiple myeloma risk
Nature Communications, Vol. 13, Núm. 1
-
Genome-wide association study on 13 167 individuals identifies regulators of blood CD34+cell levels
Blood, Vol. 139, Núm. 11, pp. 1659-1669
2021
-
The ESR1 Mutations: From Bedside to Bench to Bedside
Cancer Research
2020
-
Papillary Thyroid Cancer—Aggressive Variants and Impact on Management: A Narrative Review
Advances in Therapy, Vol. 37, Núm. 7, pp. 3112-3128
-
Parathyroid cancer: An update
Cancer Treatment Reviews, Vol. 86
2014
-
Targeted therapies for squamous cell carcinoma of the head and neck: Current knowledge and future directions
Cancer Treatment Reviews, Vol. 40, Núm. 3, pp. 390-404